Topic archive

Infusion, Renal & Respiratory Therapy

MedTech Current publications and recall entries tagged Infusion, Renal & Respiratory Therapy.

Device RecallsRecall Brief

FDA Expands BD Alaris Pump Infusion Set Class I Recall

FDA has expanded the Class I recall involving BD Alaris Pump Infusion Sets used with the Alaris Pump Module Model 8100 after updated testing showed that some sets may perform substantially worse than previously disclosed at low flow rates and low bolus volumes.

Device RecallsFDA Class II Recall Watch: 28 September–4 October 2026

Tandem recalls beta t:slim mobile app after Libre 3 Plus pairing failure

Losing CGM connectivity changes how the insulin pump operates: users must manage delivery in manual mode without the app’s glucose values or automated control. For connected-device teams, the failure links release controls and sensor-compatibility testing to the ability to restore a working production version quickly.

Device RecallsRecall Brief

FDA Classifies Draeger VentStar Resus Neo Recall as Class I

FDA has classified the recall of Draeger VentStar Resus Neo disposable breathing circuits as Class I after cracks were found in the hose, creating a risk of leakage or disconnection that may restrict ventilation or delay therapy in infants.

Device RecallsFDA Class II Recall Watch: 20–26 September 2026

NOXBOX recalls NOxBOXi systems over potential irregular oxygen readings

Oxygen readings guide respiratory care, so affected sensors need to be identified before replacement. Clinical engineering and respiratory teams also need to coordinate with distributors on response forms and the timing of sensor changes.

Device RecallsRecall Brief

FDA Classifies BD Dialysis Convenience Kit Correction as Class I

FDA classified BD's correction of specified dialysis convenience kits and procedure trays as Class I because they contain sodium chloride ampules affected by a separate recall over product-quality and sterility-assurance concerns.

Device RecallsRecall Brief

FDA Classifies CooperSurgical INCA Infant Nasal CPAP Recall as Class I

FDA has classified the recall of specified CooperSurgical INCA Infant and Neonatal Nasal CPAP sets as Class I because a loose connection between the Stay-Flex tubing and nasal cannula may cause loss of CPAP pressure and reduced oxygenation.

Device RecallsFDA Class II Recall Watch: 14–19 September 2026

Fresenius recalls CombiSet blood tubing over connection and handling risk

Hemodialysis blood tubing is part of an extracorporeal blood circuit, so connection integrity and preparation steps have direct clinical and workflow importance. The event is notable because the field action focuses on reinforcing correct use rather than removing product, placing much of the immediate burden on training, setup verification, and clinical practice.

Device RecallsFDA Class II Recall Watch: 30 August–5 September 2026

Fresenius recalls specified 5008X blood tubing sets over blood-leak risk

Blood-circuit leakage during hemodialysis has direct treatment and patient-safety implications and can require immediate inventory segregation across dialysis programs. The event also demonstrates why quantity aggregation must respect FDA's stated units: otherwise a seemingly simple total can introduce unsupported assumptions into an otherwise evidence-based recall summary.

Device RecallsFDA Class II Recall Watch: 30 August–5 September 2026

Baxter recalls Novum IQ syringe pumps over multi-syringe infusion software issue

Infusion-pump software behavior during syringe changes can affect medication-delivery workflow at the bedside, making the event particularly relevant to clinical engineering and medication-safety teams. The correction also depends on users following a specific compatible-syringe workflow until the underlying software behavior is addressed.

Device RecallsFDA Class II Recall Watch: 30 August–5 September 2026

Fresenius recalls specified GranuFlo, NaturaLyte, and Citrasate lots over discoloration

Dialysate concentrate is a core treatment input, so visible product contamination or discoloration requires rapid inventory control in dialysis operations. The event is also a practical example of why grouped recall entries should preserve incompatible units instead of converting or summing them in ways the FDA record does not support.

Device RecallsFDA Class II Recall Watch: 23–29 August 2026

Fresenius recalls specified 2008T BlueStar hemodialysis machines following alarm complaints

Hemodialysis machines support ongoing therapy, so recurring flow, water, or temperature alarms can impose immediate operational burden on clinics even when a machine remains usable without error messages. The correction also requires facilities to coordinate backup-machine use and field replacement according to each affected system's condition.

Device RecallsFDA Class II Recall Watch: 16–22 August 2026

Medline recalls neonatal and infant heated-wire breathing circuits following thermal failures

These circuits support neonatal and infant respiratory care, so a connector failure can create both immediate clinical-management needs and broad inventory work. The recall also illustrates how one failure mode may span several FDA product classifications and catalog families while still representing a single underlying field action.

Device RecallsFDA Class II Recall Watch: 9–15 August 2026

BD recalls specified MaxGuard and MaxPlus extension sets over sterilization underdose risk

A potential sterilization underdose in products used to administer fluids into the vascular system has direct clinical and operational significance. The event also creates broad inventory work because facilities must locate specified lots across storage and use locations, discontinue affected product, and manage destruction, quarantine, replacement, and downstream notification.